Detalles de la búsqueda
1.
[Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient].
Rinsho Ketsueki
; 65(2): 74-77, 2024.
Artículo
en Japonés
| MEDLINE | ID: mdl-38448001
2.
Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone.
Int J Clin Pharmacol Ther
; 61(11): 515-519, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622674
3.
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
Rinsho Ketsueki
; 64(2): 133-136, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36990734
4.
[Outcomes of COVID-19 due to omicron variant infection complicated with hematological disorders].
Rinsho Ketsueki
; 64(1): 3-8, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36775303
5.
Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.
J Clin Pharm Ther
; 47(4): 477-482, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778985
6.
[Rapid response of secondary plasma cell leukemia after carfilzomib and dexamethasone therapy].
Rinsho Ketsueki
; 63(2): 111-113, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35264500
7.
[Complete response with tirabrutinib for relapsed and refractory Bing-Neel syndrome].
Rinsho Ketsueki
; 63(7): 770-775, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35922946
8.
[SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders].
Rinsho Ketsueki
; 63(4): 247-253, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35491212
9.
[Novel germline SAMD9 mutation in an elderly patient with myelodysplastic syndrome].
Rinsho Ketsueki
; 63(8): 865-869, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36058856
10.
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma.
Ann Hematol
; 100(11): 2745-2754, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333665
11.
Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series.
J Clin Pharm Ther
; 46(6): 1792-1795, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33960000
12.
[Practical management of the patients with hematological diseases during the COVID-19 pandemic in Japan].
Rinsho Ketsueki
; 62(2): 115-124, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-33678770
13.
[Severe thrombocytopenia after COVID-19 mRNA vaccination].
Rinsho Ketsueki
; 62(12): 1684-1687, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-35022337
14.
[Successful steroid pulse therapy for COVID-19 associated respiratory failure initially mimicking bortezomib-induced lung injury].
Rinsho Ketsueki
; 62(1): 30-34, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-33551422
15.
[Multiple myeloma with light chain deposition disease showing needle-like crystal inclusions in plasma cells and macrophages in multiple organs].
Rinsho Ketsueki
; 61(11): 1620-1624, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33298657
16.
[Analysis of anti-SARS-CoV-2 IgG antibodies in hematologic patients with asymptomatic or mildly symptomatic COVID-19 infections].
Rinsho Ketsueki
; 61(10): 1459-1463, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33162440
17.
[HHV-8-positive Castleman's disease with rapidly progressing multiorgan failure mimicking TAFRO syndrome].
Rinsho Ketsueki
; 61(10): 1497-1501, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33162447
18.
[Pomalidomide/cyclophosphamide/dexamethasone combination therapy for relapsed/refractory multiple myeloma accompanied by extramedullary lesions].
Rinsho Ketsueki
; 61(1): 20-26, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-32023597
19.
[Retrospective analysis of nosocomial COVID-19: a comparison between patients with hematological disorders and other diseases].
Rinsho Ketsueki
; 61(8): 857-864, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-32908046
20.
[Impact of time to hematological response on survival in patients treated with azacytidine: a single-center retrospective study].
Rinsho Ketsueki
; 60(8): 897-902, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31484886